Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study

Descripción del Articulo

Purpose: To assess histopathology and outcomes following primary enucleation of eyes with retinoblastoma presenting with neovascular glaucoma (NVG). Methods: This was an international multi-centre case series study across five continents. Retrospective review of patient charts was performed for all...

Descripción completa

Detalles Bibliográficos
Autores: Negretti, GS, Ushakova, T, Yuri, S, Vladimir, P, Berry, JL, Pike, S, Shields, CL, Hubbard, GB,, III, Eiger-Moscovich, M, Pe'er, J, Staffieri, SE, Elder, JE, McKenzie, JD, Ahmad, A, Hussain, M, Casavilca-Zambrano, S, Alarcon-Leon, S, Yousef, YA, Mohammad, M, Tanabe, M, Arazi, M, Fabian, ID, Goldstein, S, Kaliki, S, Sagoo, MS, Reddy, MA
Formato: artículo
Fecha de Publicación:2024
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/408
Enlace del recurso:https: //doi.org/10.1097/IAE.0000000000004340
https://hdl.handle.net/20.500.14703/408
Nivel de acceso:acceso abierto
Materia:High-Risk Histopathology
Neovascular Glaucoma
Oncology
Retinoblastoma
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_49526e2b5e2bcc40bcd97fe553918421
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/408
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling PublicationNegretti, GSUshakova, TYuri, SVladimir, PBerry, JLPike, SShields, CLHubbard, GB,, IIIEiger-Moscovich, MPe'er, JStaffieri, SEElder, JEMcKenzie, JDAhmad, AHussain, MCasavilca-Zambrano, SAlarcon-Leon, SYousef, YAMohammad, MTanabe, MArazi, MFabian, IDGoldstein, SKaliki, SSagoo, MSReddy, MA2025-02-05T17:29:53Z2025-02-05T17:29:53Z2024https: //doi.org/10.1097/IAE.0000000000004340https://hdl.handle.net/20.500.14703/408RetinaPurpose: To assess histopathology and outcomes following primary enucleation of eyes with retinoblastoma presenting with neovascular glaucoma (NVG). Methods: This was an international multi-centre case series study across five continents. Retrospective review of patient charts was performed for all patients undergoing primary enucleation for retinoblastoma (n=1420) using a standardised data-collection spreadsheet. Clinical features, pathological grade, and outcomes were compared between NVG patients and those with an American Joint Commission on Cancer (AJCC) 8th edition clinical stage of cT2. High-risk histopathology was defined as AJCC 8th edition pathological stage ≥pT2b. Results: NVG was seen in 224/1420 (16%) patients. Mean age at presentation of those with NVG was 30 months (median 25, range 0-120 months) and 131(58%) patients had high-risk histopathology. The univariate logistic regression odds ratio for NVG predicting high-risk histopathology was 1.73 (95% confidence interval: 1.3 to 2.31) and from multivariate logistic regression was 1.77 (95% confidence interval: 1.23 to 2.56). Patients with a longer duration of symptoms (p=0.03), buphthalmos (p=0.02) and ectropion uveae (p<0.01) were more likely to have high-risk histopathology. Patients with NVG were more likely to develop metastasis than cT2 patients (p=0.04). Conclusions: There is a significant association between NVG at presentation, high-risk histopathology and metastatic risk.application/pdfengLippincott Williams and WilkinsUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/High-Risk HistopathologyNeovascular GlaucomaOncologyRetinoblastomahttps://purl.org/pe-repo/ocde/ford#3.02.21Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Studyinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/aceptedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINAL20.500.14703/408oai:repositorio.inen.sld.pe:20.500.14703/4082026-02-13T01:21:56.195Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessmetadata.onlyhttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
dc.title.none.fl_str_mv Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
title Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
spellingShingle Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
Negretti, GS
High-Risk Histopathology
Neovascular Glaucoma
Oncology
Retinoblastoma
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
title_full Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
title_fullStr Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
title_full_unstemmed Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
title_sort Neovascular Glaucoma as a Predictor of Retinoblastoma High-Risk Histopathology in an International Multicentre Study
author Negretti, GS
author_facet Negretti, GS
Ushakova, T
Yuri, S
Vladimir, P
Berry, JL
Pike, S
Shields, CL
Hubbard, GB,, III
Eiger-Moscovich, M
Pe'er, J
Staffieri, SE
Elder, JE
McKenzie, JD
Ahmad, A
Hussain, M
Casavilca-Zambrano, S
Alarcon-Leon, S
Yousef, YA
Mohammad, M
Tanabe, M
Arazi, M
Fabian, ID
Goldstein, S
Kaliki, S
Sagoo, MS
Reddy, MA
author_role author
author2 Ushakova, T
Yuri, S
Vladimir, P
Berry, JL
Pike, S
Shields, CL
Hubbard, GB,, III
Eiger-Moscovich, M
Pe'er, J
Staffieri, SE
Elder, JE
McKenzie, JD
Ahmad, A
Hussain, M
Casavilca-Zambrano, S
Alarcon-Leon, S
Yousef, YA
Mohammad, M
Tanabe, M
Arazi, M
Fabian, ID
Goldstein, S
Kaliki, S
Sagoo, MS
Reddy, MA
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Negretti, GS
Ushakova, T
Yuri, S
Vladimir, P
Berry, JL
Pike, S
Shields, CL
Hubbard, GB,, III
Eiger-Moscovich, M
Pe'er, J
Staffieri, SE
Elder, JE
McKenzie, JD
Ahmad, A
Hussain, M
Casavilca-Zambrano, S
Alarcon-Leon, S
Yousef, YA
Mohammad, M
Tanabe, M
Arazi, M
Fabian, ID
Goldstein, S
Kaliki, S
Sagoo, MS
Reddy, MA
dc.subject.none.fl_str_mv High-Risk Histopathology
Neovascular Glaucoma
Oncology
Retinoblastoma
topic High-Risk Histopathology
Neovascular Glaucoma
Oncology
Retinoblastoma
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Purpose: To assess histopathology and outcomes following primary enucleation of eyes with retinoblastoma presenting with neovascular glaucoma (NVG). Methods: This was an international multi-centre case series study across five continents. Retrospective review of patient charts was performed for all patients undergoing primary enucleation for retinoblastoma (n=1420) using a standardised data-collection spreadsheet. Clinical features, pathological grade, and outcomes were compared between NVG patients and those with an American Joint Commission on Cancer (AJCC) 8th edition clinical stage of cT2. High-risk histopathology was defined as AJCC 8th edition pathological stage ≥pT2b. Results: NVG was seen in 224/1420 (16%) patients. Mean age at presentation of those with NVG was 30 months (median 25, range 0-120 months) and 131(58%) patients had high-risk histopathology. The univariate logistic regression odds ratio for NVG predicting high-risk histopathology was 1.73 (95% confidence interval: 1.3 to 2.31) and from multivariate logistic regression was 1.77 (95% confidence interval: 1.23 to 2.56). Patients with a longer duration of symptoms (p=0.03), buphthalmos (p=0.02) and ectropion uveae (p<0.01) were more likely to have high-risk histopathology. Patients with NVG were more likely to develop metastasis than cT2 patients (p=0.04). Conclusions: There is a significant association between NVG at presentation, high-risk histopathology and metastatic risk.
publishDate 2024
dc.date.accessioned.none.fl_str_mv 2025-02-05T17:29:53Z
dc.date.available.none.fl_str_mv 2025-02-05T17:29:53Z
dc.date.issued.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/aceptedVersion
format article
dc.identifier.doi.none.fl_str_mv https: //doi.org/10.1097/IAE.0000000000004340
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/408
dc.identifier.journal.none.fl_str_mv Retina
url https: //doi.org/10.1097/IAE.0000000000004340
https://hdl.handle.net/20.500.14703/408
identifier_str_mv Retina
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Lippincott Williams and Wilkins
dc.publisher.country.none.fl_str_mv US
publisher.none.fl_str_mv Lippincott Williams and Wilkins
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1864633508208574464
score 13.136178
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).